| Features: |
Xanthohumol is a prenylated chalcone flavonoid derived from hops (Humulus lupulus).Commonly described actions include: -Inflammation suppression: attenuation of NF-κB / STAT3 signaling -Cell-cycle and survival effects: pro-apoptotic signaling, mitochondrial stress -Angiogenesis inhibition: reduced VEGF signaling in models -Metabolic stress modulation: interference with lipid and glucose handling -Redox effects: antioxidant at low/physiologic exposure; pro-oxidant stress at higher concentrations Importantly, dose, timing, and cellular context determine which mechanism dominates. Xanthohumol is best described as chemopreventive or chemo-sensitizing, not chemoprotective: |
| Source: |
| Type: |
| SOD, or superoxide dismutase, is an important antioxidant enzyme that plays a crucial role in protecting cells from oxidative stress. It catalyzes the dismutation of superoxide radicals into oxygen and hydrogen peroxide. SOD Isoforms: There are three main isoforms of SOD: SOD1 (cytosolic): Often found to be overexpressed in certain tumors, which may help cancer cells survive in oxidative environments. SOD2 (mitochondrial): Plays a critical role in protecting mitochondria from oxidative damage. Its expression can be upregulated in some cancers, contributing to tumor growth and resistance to therapy. SOD3 (extracellular): Its role in cancer is less well understood, but it may have implications in the tumor microenvironment and metastasis. The expression levels of SOD can serve as a prognostic indicator in some cancers. For example, high levels of SOD expression have been associated with poor prognosis in certain types of tumors, potentially due to their role in promoting tumor cell survival and resistance to therapies. |
| 5014- | PEITC, | Xan, | Combination of xanthohumol and phenethyl isothiocyanate inhibits NF-κB and activates Nrf2 in pancreatic cancer cells |
| - | in-vitro, | PC, | NA |
| 5015- | Xan, | PEITC, | Comparison of the Impact of Xanthohumol and Phenethyl Isothiocyanate and Their Combination on Nrf2 and NF-κB Pathways in HepG2 Cells In Vitro and Tumor Burden In Vivo |
| - | in-vitro, | HCC, | HepG2 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:390 Target#:298 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid